The reversal of the neuroleptanalagesic combination of fentanyl/fluanisone using mixed agonist/ antagonist opioids has been investigated in the rabbit. All of the compounds studied (naloxone, nalbuphine, meptazinol, butorphanol, buprenorphine, pentazocine, doxapram) reversed the respiratory depression and sedation produced by fentanyl/f1uanisone. Fentanyl/f1uanisone produced profound analgesia for 180 min, which was rapidly and completely antagonized by naloxone. The mixed agonist/antagonist opioids produced a reduction in the degree of analgesia but, in contrast to naloxone, analgesic activity persisted from 120 min (meptazinol) to 420 min (buprenorphine). Administration of buprenorphine to rabbits anaesthetized with fentanyl/f1uanisone and midazolam confirmed that the reversal of respiratory depression was accompanied by the return of arterial pH, PC02 and PC02 to preanaesthetic values.
Summary
The reversal of the neuroleptanalagesic combination of fentanyl/fluanisone using mixed agonist/ antagonist opioids has been investigated in the rabbit. All of the compounds studied (naloxone, nalbuphine, meptazinol, butorphanol, buprenorphine, pentazocine, doxapram) reversed the respiratory depression and sedation produced by fentanyl/f1uanisone. Fentanyl/f1uanisone produced profound analgesia for 180 min, which was rapidly and completely antagonized by naloxone. The mixed agonist/antagonist opioids produced a reduction in the degree of analgesia but, in contrast to naloxone, analgesic activity persisted from 120 min (meptazinol) to 420 min (buprenorphine). Administration of buprenorphine to rabbits anaesthetized with fentanyl/f1uanisone and midazolam confirmed that the reversal of respiratory depression was accompanied by the return of arterial pH, PC02 and PC02 to preanaesthetic values.
The use of neuroleptanalgesic anaesthetic regimens, which have been shown to provide effective surgical anaesthesia, combined with reversal using a mixed agonist/antagonist opioid to provide postoperative analgesia, appears to be a valuable refinement of current laboratory animal anaesthetic practice.
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The neuroleptanalgesic combination of fentanyl! fluanisone (Hypnorm, Janssen) has been reported to produce effective sedation and analgesia in the rabbit (Green, 1981) , and to provide surgical anaesthesia when combined with a benzodiazepine such as midazolam or diazepam (Fleck nell et al., 1983; Flecknell & Mitchell, 1984) .
These drug combinations have the advantage that the moderate respiratory depression that frequently accompanies their use can be reversed using opioid antagonists such as naloxone. If naloxone is used the analgesia produced by the opioid agonist, fentanyl, will also be reversed.
Investigations in man have demonstrated that the opioid component of anaesthetic regimens can be reversed using mixed agonist/antagonist drugs (Rifat, 1972; Robertson & Laing, 1980; Latasch et al., 1984; Moldenhauer et al., 1985) . This technique, originally described 'anesthesie/ analgesique seqentielle' (De Castro & Viars, 1968) , has the advantage of providing continued analgesia in the postoperative period, without respiratory depression.
Initial studies of the agonist and antagonist properties of buprenorphine, a longacting opioid, showed that it could antagonize some of the effects of morphine and was able to reverse the narcosis produced by etorphine/ methotrimeprazine (Small Animal Immobilon, Reckitt & Coleman) in baboons (Cowan et al., 1977) . A preliminary report suggested that buprenorphine could be employed in a similar manner in rabbits (Flecknell, 1985) and has now been used extensively in this laboratory. Buprenorphine appeared to have a prolonged analgesic action, but this effect was evaluated subjectively.
The aim of the present study was to obtain an objective assessment of the efficacy of mixed agonist/antagonist opioids in reversing some of the effects of fentanyllfluanisone neuroleptanalgesia, while maintaining analgesic activity.
Materials and methods
Adult New Zealand White rabbits (bodyweight 2'6±0'15 kg; mean± SD) of conventional microbial status were obtained from a commercial supplier and housed under standard laboratory conditions until required for experiment (temperature 18±2°C; r.h. 45070;light: dark cycle, 14: 10 h) .
Each group of rabbits (n = 5) received O·3 mll kg intramuscularly (i.m.) of the commercial preparation Hypnorm (equivalent to 0'095 mg/kg fentanyl, 3 mg/kg f1uanisone) (suppliers of all compounds used are listed in Table 1 ). This was followed 15 min later by either naloxone [0'005 mg/kg intravenously (i.v.), 0·01 mg/kg i.v., or O' 1mg/kg i.v.], buprenorphine (O'3 mg/ kg i.v.), butorphanol (0' 5 mg/kg i.v.), nalbuphine (4 mg/kg i.v.), pentazocine (5 mg/kg i.v.), meptazinol (to mg/kg i.v.), or by the respiratory stimulant doxapram (5 mg/kg i.v.) or saline (2' 5 ml i.v.). All of the compounds used were diluted with 0,9% saline to provide a total volume for injection of 2· 5 ml, to facilitate a double-blind experimental design. Thus both the operator of the analgesiometer and the research worker administering the drug were unaware of the identity of the compounds being tested.
The analgesic activity was assessed using an analgesiometer which delivered a thermal stimulus to the skin (Wootton et al., 1988) . A localized skin-twitch in response to the heating was used as the end-point. The stimulus was discontinued after 15 s if a response had not been obtained, to prevent any skin damage. The method of using the analgesiometer varied slightly from that described by Wootton et al. (1988) in that the rabbits were in open cardboard transport boxes rather than restraining devices, to allow greater freedom of movement during the experiment. The analgesiometer was hand-held and focused on the skin for each heat stimulus.
Respiratory rate was counted at set intervals during the experiment and the degree of sedation was assessed using a simple scoring system (Table 2 ).
An additional group of four rabbits were anaesthetized using halothane, nitrous oxide and oxygen and catheters implanted in the carotid artery and jugular vein. The catheters were exteriorized to enable subsequent intravenous dosing and monitoring of physiological variables. Two days later, respiratory rate, arterial blood pressure and heart rate were recorded and blood was taken for arterial blood gas analysis. The rabbits then received Hypnorm (0' 3 mllkg i.m.) and midazolam (1 mg/kg i.v.), followed 30 min later by buprenorphine (0'05 mg/kg Lv.). Measurements of the variables listed above were continued at to-min intervals for 70 min. The onset and duration of a depth of anaesthesia, sufficient to allow surgical procedures to be undertaken, was assessed by monitoring the absence of pedal withdrawal and ear pinch reflexes. Previous experience of this method of assessment prior to carrying out surgery in a large number of rabbits has confirmed its reliability in judging an adequate depth of anaesthesia.
Statistical methods
There was considerable individual variation in control measurements of respiratory rate and skin-twitch response, although reproducible responses were obtained with each individual animal. The within group variability is indicated in Table 3 , which lists the mean and standard deviations of each group at t = -15 and t = 5 min. The drug effects at a given time were compared for each group of rabbits with the control values obtained at t = -15 min using Student's paired t-test. In addition, an attempt was made to evaluate the effect of each drug by fitting a non-linear model, using the computer program MLP (Maximum Likelihood Program; Ross, 1980) . In only 4 of the 10 experiments was 149 this successful, however; although in each case the results were consistent with those obtained by Student's paired t-test.
Results

Reversal of respiratory depression
Administration of fentanyl/fluanisone (Hypnorm) produced a marked depression in respiratory rate, which then gradually increased to the pre-anaesthetic rate. in the saline control group (Fig. 1 ). The respiratory rate was significantly depressed between 15 and 150min (P<0'05) after administration of Hypnorm.
Administration of naloxone at all three dose rates (0'005,0'01,0,1 mg/kg) caused a prompt reversal of respiratory depression (Fig. 1) . A significant elevation in respiratory rate was seen 5 min after administration of 0'1 mg/kg naloxone and 5 and 15 min after administration of 0·01 mg/kg naloxone. Respiratory rate was not significantly different (P> 0 '1) from the preanaesthetic rate within 5 min (0'005 mg/kg), 15 min (0'1 mg/kg) and 30 min (0' 01 mg/kg) post injection. Table 3 . Respiratory rate (breaths/min), skin twitch time (control = 0 s) and activity score in 10 groups of rabbits at 15 min prior to administration of Hypnorm (control, t= -15) rate 5 min after administration of each of these opioids. The respiratory stimulant, doxapram, also produced a rapid reversal of respiratory depression. Table 4 provides a summary of these effects.
Reversal of sedation
The mean activity score was markedly reduced in all rabbits after administration of fentanyl! fluanisone. In the control group of animals which received a saline injection, activity scores increased gradually and were no longer significantly reduced at 120 min (P>O·I) (Fig.   3 ).
Administration of doxapram increased activity, but activity scores remained below pre-anaesthetic values until 45 min after administration (P<0·05). Naloxone (Fig. 3 ) produced a prompt increase in activity, but scores also remained below pre-anaesthetic values until 90 min (0' 005 mg/kg), 45 min (0' 01 mg/kg) and 60 min (0' I mg/kg) after administration (P<0·05).
Buprenorphine, butorphanol, Administration of one of the mixed agonist! antagonist compounds buprenorphine, butorphanol, meptazinol, nalbuphine and pentazocine, produced a prompt reversal of respiratory depression (Fig. 2) . The respiratory rate was not significantly different (P> O·I) from the pre-anaesthetic Fig. 3 . Activity score in three groups of 5 rabbits after administration of Hypnorm (0-3 ml/kg i.m. at time = -15 min). Activity score was significantly reduced (P< 0'05) between 1 = 0 and 1= 90 min (saline control group, D), t = 0 and 1 = 90 min (naloxone, O'005 mg/kg, X) and 1 = 0 and 1=45 (naloxone, 0·1 mg/kg, v). Fig. 4 . Activity score in three groups of 5 rabbits after administration of Hypnorm (0' 3 m1/kg. i.m. at time = -15 min). Activity score was significantly (P<0'05) reduced between 1= 0 and 1= 5 min (Nalbuphine, 0), 1=0 and 1= 60 min (buprenorphine, X) and 1 = 0 and 1 = 15 min (butorphanol, v). Fig. 6 . Increase in skin twitch latency in response to a thermal stimulus in three groups of 5 rabbits. Skin twitch time is the increase over control measurement at time = -IS min, immediately prior to administration of Hypnorm (0'3 ml/kg, i.m.). Nalbuphine (4 mg/kg i.v., D), buprenorphine (0'03 mg/kg i.v., X) or butorphanol (0' 5 mg/kg i. v., v) was administered at time=O min. Skin twitch latency was significantly (P<0'05) prolonged between 1=0 and 1=180min (nalbuphine), 1=0 and 1 = 420 (buprenorphine) and 1 = 0 and 1= ISOmin (butorphanol). meptazinol, nalbuphine and pentazocine all produced a reversal of the sedative effects of fentanyl/fluanisone. The activity scores remained significantly depressed (P<O'05) until15-60rnin after administration of the agonist/antagonist compound (Fig. 4, Table 4 ).
Analgesic activity
Fentanyl/fluanisone produced an increase in skin twitch latency which was significantly prolonged Naloxone (0-1 mg/kg, 0-01 mg/kg and 0-005 mg/kg) produced a reversal of the analgesic activity of fentanyl/fluanisone (P>O-l) (Fig. 5 ), but skin twitch latency was still significantly elevated (P< 0 -05) for 60 min. Buprenorphine, butorphanol, meptazinol, nalbuphine and pentazocine all produced a reduction in the degree of analgesia, but analgesic activity persisted for periods varying from 120 min (meptazinol) to 420 min (buprenorphine) (P<0-05) (Fig. 6) . These effects are summarized in Table 4 .
Discussion
The type of pain produced by analgesiometry is qualitatively and quantitatively different from that experienced clinically, but analgesic tests have repeatedly been shown to predict clinical therapeutic activity in man (Taber, 1974) . Veterinary clinical experience also indicates that drugs which are effective in analgesic tests are effective in alleviating clinical pain in animals. Although analgesic tests appear to indicate the clinical efficacy of pain-relieving drugs, tests in animals generally predict doses that are around 10 times greater than those which are required clinically. It is therefore possible that the compounds tested in this study may be effective in alleviating postoperative pain at considerably lower dose rates. It seems reasonable to suggest, however, that if there is a demonstrable effect using analgesiometry, then there will also be an effect in reducing postoperative pain. Until objective methods of assessing clinical pain in animals have been developed, this uncertainty will remain as to the relationship between effects measured using analgesiometry and the clinical efficacy of compounds in animals.
Radiant heat has been widely used as a noxious stimulus in analgesic tests (Flecknell, 1984) _ Selection of the method of application of the stimulus was influenced primarily by the requirements that the animal: should be able to terminate the noxious stimulus; should have Effects in chronically catheterized rabbits Fentanyl/fluanisone and midazolam produced a marked reduction in respiratory rate and a parallel reduction in PC02, elevation of PC02 and reduction of pH (Figs 7 and 8) . Arterial blood pressure and heart rate were not significantly different from pre-anaesthetic values (P> 0-1) (Fig. 7) _ Administration of buprenorphine produced a small but non-significant elevation in heart rate (P>O'l), and no significant changes in blood pressure. Respiratory rate was increased following administration of buprenorphine and this was accompanied by a consequent increase in Po 2 , reduction in PC02 and increase in pH (Figs 7 and 8) . reasonable freedom of movement during the study period; should not be held in a restraining device; and that the stimulus used should be nondamaging. The apparatus described by Wootton et al. (1988) fulfIls these requirements. Alternative techniques (Lightowler & Smith, 1963; Saarnivaara, 1969; Zhongfu et al., 1981; Ayhan et al., 1983; McCallister et al., 1986) , require restraint or appear to use more severe stimuli than were necessary for the present study.
As has been reported previously (Green, 1981) , fentanyllfluanisone produced a marked depression of respiratory rate, which persisted for several hours. The prolonged respiratory depression was associated with sedation and persistent analgesia. The long duration of analgesia following the administration of Hypnorm might not be expected, since fentanyl is considered to be a short acting opioid in the rabbit (Hess et al., 1972; Green, 1981) . The dose used to achieve neuroleptanalgesia is considerable, however, and the duration of analgesia is consistent with fentanyl kinetic studies reported by others (Hess et al., 1971) .
Persistent analgesia is desirable after an animal has undergone surgery, but prolonged respiratory depression is not. Although no rabbits died in the present study, respiratory depression is a hazard of deep anaesthesia, particularly in rabbits of conventional microbial status which frequently have pulmonary disease.
The degree of respiratory depression caused by fentanyl/fluanisone, either alone or in combination with midazolam, is similar to that produced by the other anaesthetic combination of ketamine/xylazine (White & Holmes, 1976) and is considerably less severe than that produced by pentobarbitone at equivalent levels of anaesthesia (Flecknell et al., 1983) . Nevertheless, it may be preferable to reverse the respiratory depression of fentanyI/fluanisone and naloxone has frequently been used to achieve this. The present study confirmed the efficacy of naloxone, but demonstrated that the reversal of respiratory depression and sedation is paralleled by a reduction in the analgesic effect of the fentanyl (Figs I, 3 and 5 ). This would be a disadvantage 153 after painful surgery. It is of interest that the lower dose of naloxone reversed the respiratory depression and sedation, but appeared to preserve the analgesic effect of fentanyl; this suggests that the lowest possible dose of naloxone should be used.
Doxapram is a respiratory stimulant and has been advocated as an alternative to naloxone for the reversal of respiratory depression after the use of neuroleptanalgesics such as Hypnorm (Green, 1981; Lumb & Jones, 1984) . Doxapram reversed the respiratory depression but the analgesic effect of fentanyl was also apparently reduced. This may be a consequence of a general central nervous system stimulation effect as doxapram has no specific narcotic antagonist properties.
All of the mixed agonist-antagonist drugs were effective in reversing the respiratory depression produced by fentanyl. These compounds also maintained varying degrees of analgesia. The duration of analgesia was meptazinol < pentazocine < butorphanol < nalbuphine < buprenorphine (Table 4 ). The dose rates selected for the present study were based on clinical experience and on previously published data (pircio et al., 1976; Cowan et al., 1977; Stephens et al., 1978; Murai & Ogura, 1978; Flecknell, 1984) . It is possible that more profound and more prolonged analgesia might be achieved by increasing the dose rates of the mixed agonist/antagonist opioids and further studies are required to determine dose-response patterns for these compounds in the rabbit under these circumstances.
The sedation produced by Hypnorm was partially reversed by all of the compounds used in this study. The persistent reduction in activity levels was almost certainly from the butyrophenone tranquillizer, fluanisone, combined with fentanyl in Hypnorm.
The methods used to assess activity and respiratory depression are not ideal, but provided a non-invasive means of assessing the effects of Hypnorm and the antagonist effects of the compounds used. Respiratory depression caused by opioids affects both the rate and depth of respiration and it is possible for respiratory rate to be maintained but tidal volume to be reduced. In practice, the results of blood gas analysis in both the present study and previous investigations (Flecknell et al., 1983) indicate that respiratory rate provides a reasonable measure of respiratory depression.
The use of an activity score may not be an entirely objective measure of the degree of sedation. The results may be affected by interactions between the observer and the rabbits and vary between observers. Given these limitations, the scoring system does appear to provide a reasonable index of sedation, but detailed activity monitoring might detect more subtle effects on locomotor activity. The present system also provided no indication as to whether the reversal of sedation was accompanied by a return to normal feeding and drinking.
Despite the reservations discussed earlier concerning the duration and efficacy of analgesics when used in the clinical situation, some recommendations can be made, based on the present study. Neuroleptanalgesic
